Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023

Rhea-AI Summary

Unicycive Therapeutics, Inc. (Nasdaq: UNCY) announced that its CEO will participate in two investor conferences in December 2023, presenting at the Noble Capital Markets 19th Annual Emerging Growth Equity Conference on December 4, 2023, and the 2023 Benchmark Discovery One-on-One Investor Conference on December 7, 2023.

LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will participate in two upcoming investor conferences in December 2023.

Noble Capital Markets 19th Annual Emerging Growth Equity Conference (NobleCon)
Presentation: Monday, December 4, 2023 at 3:30 pm ET
Boca Raton, FL
A high-definition video webcast of the presentation will be available the following day on the Unicycive website under the Investors section: Events and Presentations.

2023 Benchmark Discovery One-on-One Investor Conference
December 7, 2023
New York, NY

About Unicycive Therapeutics

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in late preclinical development for the treatment of acute kidney injury. For more information, please visit Unicycive.com and follow us on LinkedIn and YouTube.

Investor Contact:

ir@unicycive.com
(650) 543-5470

SOURCE: Unicycive Therapeutics, Inc.

 

FAQ

What is the company name and ticker symbol of the clinical-stage biotechnology company participating in the investor conferences in December 2023?

Unicycive Therapeutics, Inc. (Nasdaq: UNCY)

When and where will the CEO of Unicycive Therapeutics, Inc. be presenting at the Noble Capital Markets 19th Annual Emerging Growth Equity Conference?

The CEO will present on Monday, December 4, 2023, at 3:30 pm ET in Boca Raton, FL.

Where can investors find the high-definition video webcast of the presentation at the Noble Capital Markets 19th Annual Emerging Growth Equity Conference?

The webcast will be available the following day on the Unicycive website under the Investors section: Events and Presentations.

When and where will the CEO of Unicycive Therapeutics, Inc. be participating in the 2023 Benchmark Discovery One-on-One Investor Conference?

The CEO will participate on December 7, 2023, in New York, NY.